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RATIONALE: Chronic spontaneous urticaria (CSU) lesions are charac-
terized by infiltrates of eosinophils and basophils. Studies have suggested a
role for the PGD2/CRTh2 and eotaxin/CCR3 pathways in eosinophil
recruitment to CSU lesions. Eosinophils produce PGD2 in response to eo-
taxin, however the effects of PGD2 on CCR3 expression have not been
examined. Therefore, we explored CCR3 and CRTh2 as shared recruit-
ment/activation pathways for eosinophils and basophils.
METHODS: We recruited adult CSU subjects (n522) and non-allergic
controls (n58). Whole blood was analyzed for baseline CCR3 and CRTh2
expression on basophils and eosinophils by flow cytometry. CCR3
expression was examined in samples stimulated with PGD2 in the presence
or absence of a CRTh2 antagonist (AZD1981).
RESULTS: Basophils from CSU subjects exhibited lower CRTh2 and CCR3
at baseline compared to healthy controls (p50.0277 and p50.0001).
Eosinophil CRTh2 expression was also significantly lower in CSU subjects
compared to controls (p50.0049). CRTh2 and CCR3 were positively
correlated on basophils (p50.0157) and eosinophils (p50.0036). Increasing
concentrations of PGD2 reduced eosinophil CCR3 expression to a lesser extent
in CSU subjects compared to controls (AUC 521.7 vs 624.6, p<0.0001).
AZD1981 inhibited reductions in eosinophil CCR3 induced by PGD2 (10
-6.5
M) in CSU subjects (p50.0001) and healthy subjects (p50.0469).
CONCLUSIONS: Reductions in basophil and eosinophil CRTh2 and
CCR3 surface expression were positively correlated in CSU subjects. PGD2
exposure reduced eosinophil CCR3 expression in CSU and healthy subjects
which was partially inhibited by CRTh2 antagonism. Further studies exam-
ining the coordination of these pathways may provide insights into the
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RATIONALE: Urticaria/angioedema are the most frequent clinical
manifestations of drug hypersensitivity. However, data from Latin
America on this topic is limited.
METHODS: A retrospective, cross-sectional study assessed characteris-
tics of drug induced urticaria (DIU) and angioedema using the European
Network of Drug Allergy questionnaire in 22 allergy units from 11 Latin
American countries. Clinical characteristics, demographics, causal rela-
tionship with specific drugs, confirmatory diagnostic evaluation, and
treatment were assessed.
RESULTS: From1,031 hypersensitivity drug reactions (HDR) evaluated,
697 (67.6%) met DIU diagnostic criteria. The mean age was 35.4-year-old
(1-85); Female:Male for adults >17 y/o was 2.6:1 whereas for children/
adolescent 0-17 y/o was 0.87:1 (P<0.0001).
Severe reactions were present in 21.6% of non-atopic and 15% of atopic
patients (p<0.05). A history of a previous HDR to the causal drug was
present in 13.3% of patients. The most frequently reported DIU inducers
were nonsteroidal anti-inflammatory drugs (NSAIDs) (68%) followed by
beta lactam (13%) and non-beta lactam (8%) antibiotics. Provocation tests
(n5320) were performed in 244 cases (35%) with NSAIDs (68.1%), beta-
lactams (12.8%) and non-beta lactam antibiotics (6.6%) being the most
frequent drugs challenged. Skin prick (16.6%) and intracutaneous (10.4%)
tests were the second and third most frequent diagnostic procedures
performed. Antihistamines (79.5%) and corticosteroids (60.1%) were the
most frequently prescribed therapies.
CONCLUSIONS: Female gender predominated in adults but not in
children/adolescents. Personal history of atopy was associated with less
severe reactions. NSAIDs and antibiotics were the most common drugs
implicated. These results provide much needed data on the prevalence and
nature of HDRs in Latin America.
